C23H29N5O4
Neat
439.52
1246610-74-1; N-Boc Alogliptin; Alogliptin Impurity 48; Alogliptin Related Compound 29; CN6934BAY4; SCHEMBL13185937; 2-[[6-[(3R)-3-tert-butoxycarbonylamino-1-piperidinyl]-3, 4-dihydro-2, 4-dioxo-3-methyl-1(2H)-pyrimidinyl]methyl]benzonitrile; 1, 1-Dimethylethyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-1, 2, 3, 6-tetrahydro-1-methyl-2, 6-dioxo-4-pyrimidinyl]-3-piperidinyl]carbamate; Carbamic acid, N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-1, 2, 3, 6-tetrahydro-1-methyl-2, 6-dioxo-4-pyrimidinyl]-3-piperidinyl]-, 1, 1-dimethylethyl ester; tert-butyl (R)-(1-(3-(2-cyanobenzyl)-1-methyl-2, 6-dioxo-1, 2, 3 and 6-tetrahydropyrimidin-4-yl)piperidin-3-yl)carbamate
tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-1-methyl-2 and 6-dioxopyrimidin-4-yl]piperidin-3-yl]carbamate
InChI=1S/C23H29N5O4/c1-23(2,3)32-21(30)25-18-10-7-11-27(15-18)19-12-20(29)26(4)22(31)28(19)14-17-9-6-5-8-16(17)13-24/h5-6,8-9,12,18H,7,10-11,14-15H2,1-4H3,(H,25,30)/t18-/m1/s1